Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

The impact of bridging therapy (BT) administered between leukapheresis and chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL) is unclear. We evaluated the influence of BT (systemic therapy [ST], radiation therapy [RT], or combined-modality therapy [CMT]) on outcomes of 1...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Pinnix, Chelsea C., Gunther, Jillian R., Dabaja, Bouthaina S., Strati, Paolo, Fang, Penny, Hawkins, Misha C., Adkins, Sherry, Westin, Jason, Ahmed, Sairah, Fayad, Luis, Lee, Hun Ju, Nair, Ranjit, Steiner, Raphael E., Iyer, Swaminathan P., Rodriguez, M. Alma, Wang, Michael, Flowers, Christopher, Neelapu, Sattva S., Nastoupil, Loretta J.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362355/
https://ncbi.nlm.nih.gov/pubmed/32589728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001837
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker